The China-based biotech was formed in 2018 by Ascendis Pharma and an investor syndicate led by Vivo Capital. The biotech is designed to develop and commercialize Ascendis’ endocrinology ...

Proficio Capital Partners LLC acquired a new stake in Ascendis Pharma A/S (NASDAQ:ASND – Free Report) in the fourth quarter, ...

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally. The company ...

Ascendis Pharma A/S (ASND) shares rallied 10.4% in the last trading session to close at $168.84. This move can be attributable to notable volume with a higher number of shares being traded than in ...

In a report released today, Yaron Werber from TD Cowen maintained a Buy rating on Septerna, Inc. (SEPN – Research Report). The company’s shares ...

TD Cowen analyst Yaron Werber maintained a Buy rating on Nkarta (NKTX – Research Report) today. The company’s shares closed today at ...

European equities traded in the US as American depositary receipts were higher late Tuesday morning, up 0.73% to 1,435.56 on the S&P Europe Select ADR Index. From continental Europe, the gainers were ...

Wilson Therapeutics, and Ascendis Pharma. Her prior executive roles include Executive Vice President and Interim Chief Medical Officer at Ascendis Pharma, where she led clinical development ...